TherapeuticsMD reports Phase III Replenish Trial positive top-line data of TX-001HR to treat VMS

US-based healthcare company TherapeuticsMD has reported positive top-line results of its pivotal Phase III Replenish Trial of TX-001HR to treat moderate-to-severe vasomotor symptoms (VMS) due to menopause in post-menopausal women with an intact uteru …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news